Operating income before deduction of amortization: prophaselabs.com (PRPH)
The EBITDA indicator on GURU.Markets illustrates business liquidity dynamics, where the value of 0.00 expresses the metric level. ProPhase Labs, Inc. (PRPH) is scaling the implementation of Nebula NGS tests and LineaRx diagnostics, expanding its B2B network in the US. High margins in genomics offset low pricing power in mass testing, helping the company successfully pivot from saturated markets toward early cancer detection.
Summary analytical data breakdowns for ProPhase Labs (PRPH)
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- balance sheet equity data:
- business debt structure and liquidity details:
Aggregate Debt to Equity ProPhase Labs, Inc.|PRPH - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital ProPhase Labs Inc|PRPH - Company Debts|Debts to Book Value ProPhase Labs|PRPH - Company Long-Term Debt|Current Liabilities ProPhase Labs|Intermediate Coverage Ratio prophaselabs.com
- company profitability and valuation multiples indicators:
PRPH - Net Profit|Projected Future Earnings ProPhase Labs, Inc.|PRPH - Price to Earnings Ratio|Market Cap to Projected Earnings prophaselabs.com|PRPH - PEG Multiple|Company Value to EBITDA ProPhase Labs|PRPH - Operating profit before deduction of amortization|Earnings per share for the trailing year ProPhase Labs|PRPH - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months prophaselabs.com|PRPH - Earnings growth in current year|Earnings growth forecast for next year ProPhase Labs, Inc.
Analysis of all company metrics:ProPhase Labs, Inc.
Absolute operating profit measures the daily liquidity inflow from core activities, allowing for an assessment of the business's real cash efficiency prior to reporting adjustments. For ProPhase Labs, Inc. (PRPH), this metric reflects the monetization of AI platforms in cancer diagnostics, and an analysis of EBITDA chronology helps determine whether operating cash flow offsets R&D expenses to ensure capital sustainability.
Competitors of ProPhase Labs, Inc. (PRPH)
Agilent Corp (A) - Profit before interest, taxes and amortization|DGX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization illumina.com ILMN|EXAS: Operating profit EBITDA|RVTY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Bio-Rad Laboratories Inc|Anbio Corp (NNNN) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Sotera Health Company (SHC)|QDEL: Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization OPKO Health OPK|Income before deduction of interest, taxes and amortization CDNA|MRVI - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Fulgent|Standard BioTools Inc. (LAB) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization CTKB (cytekbio.com)|OSUR (OraSure) - Operating profit EBITDA|XGN: Income before deduction of interest, taxes and amortization|Operating profit EBITDA MDXH|Operating profit EBITDA Lucid Diagnostics, Inc (LUCD)|Profit before payment of interest, taxes and amortization Prenetics PRE|Operating income before deduction of amortization Insight Molecular Diagnostics, Inc. (IMDX)|Trinity Biotech Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Ainos Inc|CODX (Co-Diagnostics Corp) - Operating profit before deduction of amortization|Heart Test Labs - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Biomerica, Inc.|Profit before payment of interest, taxes and amortization CDIO|Operating profit EBITDA ONCO|Operating profit EBITDA Virax Biolabs Group Limited (VRAX)|Operating profit EBITDA BJDX (Bluejay)|Aspira Women's Health Inc - Profit before payment of interest, taxes and amortization|AXDX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Centogene CNTG|ENZ (enzo.com) - Operating profit before deduction of amortization|Fresh2 Group - Income before deduction of interest, taxes and amortization|GENE (Genetic Technologies Ltd) - Operating profit EBITDA|23andMe Inc (ME) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Psychemedics (PMD)
